A Summary of NASA Architecture Studies Utilizing Fission Surface Power Technology

Beginning with the Exploration Systems Architecture Study in 2005, NASA has conducted various mission architecture studies to evaluate implementation options for the U.S. Space Policy (formerly the Vision for Space Exploration). Several of the studies examined the use of Fission Surface Power (FSP) systems for human missions to the lunar and Martian surface. This paper summarizes the FSP concepts developed under four different NASA-sponsored architecture studies: Lunar Architecture Team, Mars Architecture Team, Lunar Surface Systems/Constellation Architecture team, and International Architecture Working Group-Power Function team. The results include a summary of FSP design characteristics, a compilation of mission-compatible FSP configuration options, and an FSP concept-of-operations that is consistent with the overall mission objectives

Design Concept for a Nuclear Reactor-Powered Mars Rover

A report presents a design concept for an instrumented robotic vehicle (rover) to be used on a future mission of exploration of the planet Mars. The design incorporates a nuclear fission power system to provide long range, long life, and high power capabilities unachievable through the use of alternative solar or radioisotope power systems. The concept described in the report draws on previous rover designs developed for the 2009 Mars Science laboratory (MSL) mission to minimize the need for new technology developments

Kilowatt-Class Fission Power Systems for Science and Human Precursor Missions

Nuclear power provides an enabling capability for NASA missions that might otherwise be constrained by power availability, mission duration, or operational robustness. NASA and the Department of Energy (DOE) are developing fission power technology to serve a wide range of future space uses. Advantages include lower mass, longer life, and greater mission flexibility than competing power system options. Kilowatt-class fission systems, designated "Kilopower," were conceived to address the need for systems to fill the gap above the current 100-Wclass radioisotope power systems being developed for science missions and below the typical 100-kWe-class reactor power systems being developed for human exploration missions. This paper reviews the current fission technology project and examines some Kilopower concepts that could be used to support future science missions or human precursors

Design and Build of Reactor Simulator for Fission Surface Power Technology Demonstrator Unit

The Nuclear Systems Team at NASA Marshall Space Flight Center (MSFC) focuses on technology development for state of the art capability in non-nuclear testing of nuclear system and Space Nuclear Power for fission reactor systems for lunar and Mars surface power generation as well as radioisotope power systems for both spacecraft and surface applications. Currently being designed and developed is a reactor simulator (RxSim) for incorporation into the Technology Demonstrator Unit (TDU) for the Fission Surface Power System (FSPS) Program, which is supported by multiple national laboratories and NASA centers. The ultimate purpose of the RxSim is to provide heated NaK to a pair of Stirling engines in the TDU. The RxSim includes many different systems, components, and instrumentation that have been developed at MSFC while working with pumped NaK systems and in partnership with the national laboratories and NASA centers. The main components of the RxSim are a core, a pump, a heat exchanger (to mimic the thermal load of the Stirling engines), and a flow meter for tests at MSFC. When tested at NASA Glenn Research Center (GRC) the heat exchanger will be replaced with a Stirling power conversion engine. Additional components include storage reservoirs, expansion volumes, overflow catch tanks, safety and support hardware, instrumentation (temperature, pressure, flow) for data collection, and power supplies. This paper will discuss the design and current build status of the RxSim for delivery to GRC in early 2012

Special Topic for Nuclear CLT: Kilopower Project

NASA needs nuclear power to achieve a sustainable human presence on Lunar and Mars surfaces. Kilopower II addresses a gap in the NASA Technology Roadmaps (TA-03) for robust, sun-independent power generation in the 1 to 10 kWe range. NASA needs a long-life, low-cost power option for missions where solar is not practical. Future Exploratory Missions require a reliable source of power Lunar/Mars explorations including ISRU propellant production and crew life support and operations, for which there is no off-the-shelf solution. KRUSTY serves as a baseline for on follow-on human missions with multiple stand-alone units that provide redundancy/fault tolerance and flexibility for re-use at multiple sites with power needs of 1 to 10 kWe throughout the solar system (e.g. permanently-shaded lunar craters, subsurface Europa science, deep space electric propulsion, others.

Association of raised titres of antibodies to Chlamydia pneumoniae with a history of pre-eclampsia

OBJECTIVE: To establish the prevalence of Chlamydia pneumoniae (C. pneumoniae) infection in a pregnant UK population and to investigate whether C. pneumoniae infection is more common in women with a previous history of pre-eclampsia. DESIGN: Prospective study. SETTING: Academic Hospital. POPULATION: Ninety-one pregnant women (54 parous and 37 nulliparous) at 16-22 weeks of gestation were studied. Of the parous women, 32 had a previous history of pre-eclampsia. METHODS: Peripheral blood was drawn for C. pneumoniae antibodies between 16-22 and 28-40 weeks of gestation. C. pneumoniae antibodies were measured using a solid-phase enzyme immunoassay. According to pregnancy outcome, women were categorised into normal, gestational hypertension and pre-eclampsia groups. MAIN OUTCOME MEASURES: Serum levels of IgG, IgA and IgM C. pneumoniae antibodies. RESULTS: Prevalence of seropositivity to C. pneumoniae was 77%. Parous women had significantly higher levels of IgA and IgM C. pneumoniae antibodies than nulliparous women (P < 0.04). Parous women with previous pre-eclampsia were found to have higher levels of antibodies than parous women with a normal obstetric history (P< or = 0.003). There was no difference in the antibody levels in women with different pregnancy outcomes. CONCLUSIONS: The longitudinal data do not indicate an association between C. pneumoniae infection and pre-eclampsia. However, the subgroup analysis of parous women demonstrated raised C. pneumoniae antibodies in the women with previous pre-eclampsia, and therefore suggests that there may be an association between C. pneumoniae and the disease in this group